This webinar is pending approval from CAMPEP for 1 MPCEC hour and approved by ASRT for 1 category A credit.
The learning objectives for this webinar include:
– Reviewing the role of stereotactic body radiotherapy (SBRT) in the multidisciplinary management of kidney cancer.
– Outlining the principles of SBRT for managing primary renal cell carcinoma.
– Reviewing treatment regimens, the role of post-treatment biopsy and nephron-sparing approaches.
Presenter:
Shankar Siva, Ph.D., MBBS, FRANZCR
Professor, Radiation Oncologist, Peter MacCallum Cancer Centre, Australia
Professor Shankar Siva leads the stereotactic body radiotherapy (SABR) service at the Peter MacCallum Cancer Centre and is an internationally recognized leader in the field. He leads five international multicentre trials through the TransTasman Radiation Oncology Group (TROG), focusing on SABR. He has over 300 peer-reviewed publications and $22 million in competitive grant funding. His current research focuses on high-tech radiotherapy delivery in the context of immunotherapy combinations, lung cancer, oligometastatic disease, kidney cancer and prostate cancer.
Moderator:
Alexander Muacevic, M.D.
Professor, European Radiosurgery Center Munich, Germany
Prof. Alexander Muacevic is the Medical Director of the European Radiosurgery Center in Munich, Germany. He holds an academic teaching position at the University of Munich Hospitals. His main clinical and scientific interest is full-body radiosurgery using advanced image-guided robotic technology. He is a trained and board-certified neurosurgeon and radiosurgeon. He also holds a European Neurosurgery Certificate. He has published over 100 scientific contributions, including full papers, book chapters, and congress proceedings. Prof. Muacevic is a member of several academic societies and the president of the International Radiosurgery Society, which has over 700 members. He is the co-founder and co-chief editor of Cureus.com.
